SEC Form 4 · accession 0001171843-16-008736
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Simard
Director · 10% Owner
Period of report
Mar 17, 2016
Accepted (ET)
Mar 22, 2016 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Mar 17, 2016 | O | 500,000 | $10.00 | D | 6,153,267 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to sellF2 | $10.00 | Mar 17, 2016 | O | 500,000 | D | Mar 20, 2014 | Mar 20, 2016 | Common Stock | 500,000 | 0 | D |
Explanation of responses
- F1On March 17, 2016, Thorpe McKenzie exercised his option to purchase 500,000 shares of the Reporting Person's common stock at a purchase price of $10 per share.
- F2On March 20, 2014, the Reporting Person sold to Thorpe McKenzie an option to purchase 500,000 shares of his common stock at a purchase price of $10 per share, which option is exercisable for a period of two years from the grant date.